COCCO, LUCIO ILDEBRANDO MARIA
 Distribuzione geografica
Continente #
NA - Nord America 92
EU - Europa 72
AS - Asia 47
Totale 211
Nazione #
US - Stati Uniti d'America 92
HK - Hong Kong 30
SE - Svezia 25
GB - Regno Unito 14
LT - Lituania 12
SG - Singapore 10
CN - Cina 7
IT - Italia 6
FI - Finlandia 4
IE - Irlanda 4
NL - Olanda 3
DE - Germania 2
RU - Federazione Russa 2
Totale 211
Città #
Ashburn 37
Hong Kong 30
Nyköping 25
Chandler 16
Singapore 10
Dublin 4
Helsinki 4
London 4
Amsterdam 2
Beijing 2
Rome 2
Urbino 2
Washington 2
Bologna 1
Chiswick 1
Frankfurt am Main 1
Hounslow 1
Kilburn 1
Prescot 1
Shanghai 1
Southwark 1
Wandsworth 1
Totale 149
Nome #
A role of PI-PLCb1 in G1/S transition in human erythroleukemia k562 cells 29
Involvement of nuclear PLC{beta}1 in lamin B1 phosphorylation and G2/M cell cycle progression 22
Effect of Erythropoietin Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients 20
Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS 19
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-ami ne (A443654) in T-cell acute lymphoblastic leukemia 19
Toxicity of antimony trioxide nanoparticles on human hematopoietic progenitor cells and comparison to cell lines 18
Preclinical testing of the Akt inhibitor triciribine in T-cell acute lymphoblastic leukemia 17
Synergistic induction of PI-PLCbeta1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromes 16
Synergistic proapoptotic activity of recombinant TRAIL plus the Akt inhibitor perifosine in acute myeloid leukemia cells 15
The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation 13
Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside 13
Effect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients 11
Totale 212
Categoria #
all - tutte 4.298
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.298


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202389 0 0 0 4 9 20 1 14 16 3 8 14
2023/2024113 3 5 6 21 17 11 21 2 5 0 15 7
2024/202510 10 0 0 0 0 0 0 0 0 0 0 0
Totale 212